Novozymes

Novozymes

Provides biological solutions to customers to achieve more efficient use of raw materials, reduce energy consumption, replace traditional chemicals with more sustainable alternatives.

  • Edit
loading funding rounds…
Novo Nordisk
Novo Nordisk(exited)

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
DKK2021202220232024202520262027
Revenues0000000000000000000000000000
% growth7 %17 %2 %64 %7 %8 %7 %
EBITDA0000000000000000000000000000
% EBITDA margin35 %35 %33 %36 %38 %39 %40 %
Profit0000000000000000000000000000
% profit margin21 %21 %17 %8 %17 %18 %20 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue13 %11 %11 %----

Source: Company filings or news article, Equity research estimates

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Novozymes

Edit
Plant Response
ACQUISITION by The Mosaic Company Feb 2022
OrganoBalance GmbH
ACQUISITION by Novozymes Sep 2016
Chr. Hansen Holding A/S
ACQUISITION by Novozymes Dec 2022
TJ Technologies
ACQUISITION by Novozymes Jun 2013
Natural Industries
ACQUISITION by Novozymes Nov 2012
Delta Biotechnology
ACQUISITION by Novozymes Sep 2006
Synergia Life Sciences
ACQUISITION by Novozymes Nov 2021